Protected PCI Patient Story: Dan Eulate

Before his Protected PCI procedure, Dan Eulate could not walk to the mailbox or do daily household chores without breathing hard and feeling very out of breath. Dan knew something was wrong and was not surprised when his doctor, Dr. Alphonse Ambrosia of Banner Baywood Medical Center in Mesa Arizona, told him he needed another heart procedure. Dan, who is 47 years old, has lived with diabetes and heart complications for years and knew his heart symptoms well.

Listen to Dan’s story:

Dr. Ambrosia told Dan he was too high risk for cardiac bypass graft surgery (CABG) and recommended a protected percutaneous coronary intervention (Protected PCI) procedure. Since this would be Dan’s fourth stent procedure, Dan knew the Protected PCI procedure would open up his narrowed artery.

Dr. Ambrosia explained that Protected PCI is a PCI procedure performed with extra support from a heart pump called the Impella 2.5. He further explained the Impella 2.5 heart pump would help maintain his heart’s function, blood pressure, and blood flow, while the blockage in his coronary artery was opened and a stent was placed in the artery to keep it open. Dan agreed to the Protected PCI procedure.

Since his Protected PCI procedure, Dan has felt much better. He continues to regain his strength and confidence and is now able to resume his daily life. Dan encourages others living with coronary artery disease to talk to their cardiologist to see if the Protected PCI procedure with the Impella 2.5 heart pump is a treatment option for them.

Next Steps:

  1. Learn if Protected PCI is Right for You
  2. See how the Impella 2.5 heart pump works
  3. Read about the difference between PCI and Protected PCI procedures
  4. Read What to Expect Before, During and After a Protected PCI Procedure
  5. Learn more about complex heart disease
  6. Read more about Protected PCI

About Impella

The Impella 2.5 system is a temporary (<6 hours) ventricular support device indicated for use during high risk percutaneous coronary interventions (PCI) performed in elective or urgent, hemodynamically stable patients with severe coronary artery disease and depressed left ventricular ejection fraction, when a heart team, including a cardiac surgeon, has determined high risk PCI is the appropriate therapeutic option. Use of the Impella 2.5 in these patients may prevent hemodynamic instability which can result from repeat episodes of reversible myocardial ischemia that occur during planned temporary coronary occlusions and may reduce peri- and post-procedural adverse events.

Protected PCI and use of the Impella 2.5 is not right for every patient. Patients may not be able to be treated with Impella if they have certain pre-existing conditions, which a cardiologist can determine, such as: severe narrowing of the heart valve, severe peripheral artery disease, clots in blood vessels, or a replacement heart valve or certain heart valve deficiencies. Additionally, use of Impella has been associated with risks, including, but not limited to valvular and vascular injury, bleeding, and limb ischemia in certain patients. Learn more about the Impella devices’ approved indications for use, as well as important safety and risk information at